Terms: = Colorectal cancer AND ER, estrogen receptor AND Clinical Outcome
14 results:
1. estrogen concentration and estrogen receptor-β expression in postmenopausal colon cancer considering patient/tumor background.
Honma N; Arai T; Matsuda Y; Fukunaga Y; Akishima-Fukasawa Y; Yamamoto N; Kawachi H; Ishikawa Y; Takeuchi K; Mikami T
J Cancer Res Clin Oncol; 2022 May; 148(5):1063-1071. PubMed ID: 35032217
[TBL] [Abstract] [Full Text] [Related]
2. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
Filipits M; Rudas M; Singer CF; Fitzal F; Bago-Horvath Z; Greil R; Balic M; Lax SF; Halper S; Hulla W; Wu NC; Liu X; Weidler J; Bates M; Hlauschek D; Gnant M; Dubsky P
ESMO Open; 2021 Aug; 6(4):100228. PubMed ID: 34371382
[TBL] [Abstract] [Full Text] [Related]
3. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract] [Full Text] [Related]
4. The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer.
Carberry S; D'Orsi B; Monsefi N; Salvucci M; Bacon O; Fay J; Rehm M; McNamara D; Kay EW; Prehn JHM
Cell Death Dis; 2018 Jan; 9(2):125. PubMed ID: 29374142
[TBL] [Abstract] [Full Text] [Related]
5. Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes.
Peng J; Ou Q; Wu X; Zhang R; Zhao Q; Jiang W; Lu Z; Wan D; Pan Z; Fang Y
Chin J Cancer; 2017 Nov; 36(1):89. PubMed ID: 29122010
[TBL] [Abstract] [Full Text] [Related]
6. Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer.
Ryan D; Carberry S; Murphy ÁC; Lindner AU; Fay J; Hector S; McCawley N; Bacon O; Concannon CG; Kay EW; McNamara DA; Prehn JH
J Transl Med; 2016 Jul; 14(1):196. PubMed ID: 27369741
[TBL] [Abstract] [Full Text] [Related]
7. [Association between colorectal cancer and estrogens].
Honma N; Arai T; Muramatsu M
Nihon Rinsho; 2014 Jan; 72(1):49-55. PubMed ID: 24597348
[TBL] [Abstract] [Full Text] [Related]
8. Aromatase in colon carcinoma.
Sato R; Suzuki T; Katayose Y; Miura K; Shiiba K; Miki Y; Kamogawa Y; Yamamoto K; Takayuki ; Egawa S; Unno M; Sasano H
Anticancer Res; 2012 Aug; 32(8):3069-75. PubMed ID: 22843875
[TBL] [Abstract] [Full Text] [Related]
9. Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor.
Sase T; Suzuki T; Miura K; Shiiba K; Sato I; Nakamura Y; Takagi K; Onodera Y; Miki Y; Watanabe M; Ishida K; Ohnuma S; Sasaki H; Sato R; Karasawa H; Shibata C; Unno M; Sasaki I; Sasano H
Int J Cancer; 2012 Nov; 131(10):2284-93. PubMed ID: 22396198
[TBL] [Abstract] [Full Text] [Related]
10. Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin.
Gordon MA; Zhang W; Yang D; Iqbal S; El-Khouiery A; Nagashima F; Lurje G; Labonte M; Wilson P; Sherrod A; Ladner RD; Lenz HJ
Pharmacogenomics; 2011 Jan; 12(1):27-39. PubMed ID: 21174620
[TBL] [Abstract] [Full Text] [Related]
11. Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer.
Press OA; Zhang W; Gordon MA; Yang D; Haiman CA; Azuma M; Iqbal S; Lenz HJ
Pharmacogenomics J; 2011 Oct; 11(5):375-82. PubMed ID: 20548329
[TBL] [Abstract] [Full Text] [Related]
12. Identification of 5 novel genes methylated in breast and other epithelial cancers.
Hill VK; Hesson LB; Dansranjavin T; Dallol A; Bieche I; Vacher S; Tommasi S; Dobbins T; Gentle D; Euhus D; Lewis C; Dammann R; Ward RL; Minna J; Maher ER; Pfeifer GP; Latif F
Mol Cancer; 2010 Mar; 9():51. PubMed ID: 20205715
[TBL] [Abstract] [Full Text] [Related]
13. Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
Jögi A; Brennan DJ; Rydén L; Magnusson K; Fernö M; Stål O; Borgquist S; Uhlen M; Landberg G; Påhlman S; Pontén F; Jirström K
Mod Pathol; 2009 Dec; 22(12):1564-74. PubMed ID: 19734850
[TBL] [Abstract] [Full Text] [Related]
14. How different are luminal A and basal breast cancers?
Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Buttarelli M; Jacquemier J; Chaffanet M; Maraninchi D; Viens P; Birnbaum D
Int J Cancer; 2009 Mar; 124(6):1338-48. PubMed ID: 19058218
[TBL] [Abstract] [Full Text] [Related]
